Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Cervical Nerve Block for Post-PFO Migraine
ChiCTR2600128158Phase 2Not yet recruiting
- Sponsor
- Fudan University Jinshan Hospital
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ropivacaine in migraine and migraine with aura (2 arms), sponsored by Fudan University Jinshan Hospital. Primary endpoint: Change in the average number of migraine days per month. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
migrainemigraine with aura
Beyond the preview
Go deeper on ChiCTR2600128158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128158.